Boyd Peter E.'s Form 4 filing
Aquestive Therapeutics, Inc.AQST · filed Jun 15, 2022
- Accession no.
- 0001628280-22-017186
- Filed
- Jun 15, 2022
- Trade date
- Jun 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $4.05K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boyd Peter E.CIK 0001739816 | Officer (SVP-Bus. Process & Info. Tech.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $0.81F1 | +$4,050 | 59,532 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple transactions at the price of $0.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.